Latest filing published 13 Nov 2018 for EQL Pharma AB.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jennie Sterning: trading record in brief
Jennie Sterning is a declared insider at 2 companies; the most frequent names are EQL Pharma and EQL Pharma AB. The record holds 5 filings, for trades running from 5 November 2018 to 13 November 2018.
The open-market record is one-sided, with 3 purchases worth €2,686 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €813.
The latest filing, published on 13 November 2018, reports a transaction in EQL Pharma AB. The most recent open-market purchase was published on 6 November 2018, 2,924 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Jennie Sterning
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,968 shares0TeckningsrättISIN SE0011844166FI:csv-ac7ead198fdb2286dc31
- 81,900 shares0TeckningsrättISIN SE0011844166FI:csv-dec6c1153ef38b4bd932
- 28,960 shares@ SEK 0.4142.8% of flowTeckningsrättISIN SE0011844166FI:csv-4089fe474dc49479f0b1Canonical exit: 4 Feb 2019 (T+90)
- 20,000 shares@ SEK 0.4230.3% of flowTeckningsrättISIN SE0011844166FI:csv-aa3c11616f7b0074d3abCanonical exit: 4 Feb 2019 (T+90)
- 16,240 shares@ SEK 0.4627.0% of flowTeckningsrättISIN SE0011844166FI:csv-597ed154dc44e5756304Canonical exit: 3 Feb 2019 (T+90)
5 of 5 declarations